1. Home
  2. CAAS vs NYXH Comparison

CAAS vs NYXH Comparison

Compare CAAS & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.67

Market Cap

133.7M

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.37

Market Cap

126.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
NYXH
Founded
N/A
2009
Country
China
Belgium
Employees
4812
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.7M
126.0M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
CAAS
NYXH
Price
$4.67
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
31.3K
369.2K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$1.26
52 Week High
$5.15
$8.59

Technical Indicators

Market Signals
Indicator
CAAS
NYXH
Relative Strength Index (RSI) 59.42 23.76
Support Level $4.12 N/A
Resistance Level $4.75 $3.43
Average True Range (ATR) 0.14 0.19
MACD -0.01 -0.15
Stochastic Oscillator 81.58 6.11

Price Performance

Historical Comparison
CAAS
NYXH

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm, through its subsidiary, is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series of power steering models, including rack and pinion power steering, integral power steering, electronic power steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: